You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Philadelphia chromosome negative chronic myelogenous leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

Recruiting
  • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

Recruiting
  • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 13, 2022

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

Not yet recruiting
  • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
  • (no location specified)
Jul 11, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • cladribine, cytarabine,venetoclax
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 22, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Beijing, China
    Peking University People's Hospital(北京大学人民医院)
Jan 3, 2022

Previously Treated PH + CML Trial in Worldwide (Bosutinib)

Terminated
Has Results
  • Previously Treated PH + CML
  • Los Angeles, California
  • +47 more
Dec 2, 2021

Blastic Phase, Childhood Acute Promyelocytic Leukemia With PML-RARA, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Completed
Has Results
  • Blastic Phase
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +24 more
Jan 13, 2021

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Myeloid Leukemia, Philadelphia Positive Trial in Worldwide (Asciminib Pediatric formulation group, Asciminib Adult formulation

Recruiting
  • Myeloid Leukemia, Philadelphia Positive
  • Asciminib Pediatric formulation group
  • Asciminib Adult formulation group
  • Boston, Massachusetts
  • +24 more
Jan 17, 2023

Acute Lymphoblastic Leukemia Trial (GRASPA)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 21, 2021

Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

Recruiting
  • Philadelphia Chromosome Positive CML
  • BCR-ABL Positive Chronic Myelogenous Leukemia
  • Amiens, France
  • +27 more
Dec 9, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023